Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases

RNA Biology

Volumn 14, Issue 5, 2017, Pages 500-513

  Ooi, Jenny Y Y ^a   Bernardo, Bianca C ^a   Singla, Saloni ^a   Patterson, Natalie L ^a   Lin, Ruby C Y ^b,c   McMullen, Julie R ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Asbestos Diseases Research Institute   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Heart disease; microRNA; miR Seq; miRNA networks; therapy

Indexed keywords

CYCLIN D1; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LONG CHAIN FATTY ACID COENZYME A LIGASE; MICRORNA; MICRORNA 31; MICRORNA 34; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; MICRORNA 4; MICRORNA LET 7E; MYC PROTEIN; NOTCH1 RECEPTOR; O FUCOSYLTRANFERASE 1; PEPTIDES AND PROTEINS; PHOSPHOPROTEIN PHOSPHATASE 1; PIWI INTERACTING RNA; PROTEIN BCL 2; PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 10; RIBOSOME RNA; SIRTUIN 1; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSFER RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VASCULOTROPIN; VINCULIN; ACSL4 PROTEIN, MOUSE; COENZYME A LIGASE; MIRN34 MICRORNA, MOUSE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTIC CONSTRICTION; ARTICLE; B CELL LYMPHOMA; BINDING SITE; CARDIAC MYOBLAST; CONTROLLED STUDY; ELECTRIC POTENTIAL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HEART DISEASE; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART TISSUE; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROMOTER REGION; PROTEIN EXPRESSION; STRESS; WESTERN BLOTTING; ADULT; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL LINE; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HEART FAILURE; HEART VENTRICLE; HUMAN; INBRED MOUSE STRAIN; MALE; METABOLISM; SEQUENCE ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; ANIMALS; CARDIOMEGALY; CELL LINE; COENZYME A LIGASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MICE; MICE, INBRED STRAINS; MICRORNAS; MYOCYTES, CARDIAC; PLACEBOS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION FACTORS;

EID: 84973091672     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2016.1181251     Document Type: Article

References (64)

1. Bernardo BC, Charchar FJ, Lin RC, McMullen JR. A microRNA guide for clinicians and basic scientists:background and experimental techniques. Heart Lung Circ 2012; 21:131-42; PMID:22154518; http://dx.doi.org/10.1016/j.hlc.2011.11.002
2. Bernardo BC, Ooi JY, Lin RC, McMullen JR. miRNA therapeutics:a new class of drugs with potential therapeutic applications in the heart. Future Med Chem 2015; 7:1771-92; PMID:26399457; http://dx.doi.org/10.4155/fmc.15.107
3. Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med 2014; 6:239ps3; PMID:24898744; http://dx.doi.org/10.1126/scitranslmed.300908
4. Ooi JYY, Bernardo BC, McMullen JR. The therapeutic potential of microRNAs regulated in settings of physiological cardiac hypertrophy. Future Medicinal Chemistry 2014; 6:205-22; PMID:24467244; http://dx.doi.org/10.4155/fmc.13.196
5. Bernardo BC, Gao XM, Tham YK, Kiriazis H, Winbanks CE, Ooi JY, Boey EJ, Obad S, Kauppinen S, Gregorevic P, et al. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PLoS One 2014; 9:e90337; PMID:24587330; http://dx.doi.org/10.1371/journal.pone.0090337
6. Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du XJ, et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A 2012; 109:17615-20; PMID:23047694; http://dx.doi.org/10.1073/pnas.1206432109
7. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Treguer K, Carmona G, Bonauer A, et al. MicroRNA-34a regulates cardiac ageing and function. Nature 2013; 495:107-10; PMID:23426265; http://dx.doi.org/10.1038/nature11919
8. Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C, Latimer PA, et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 2012; 110:71-81; PMID:22052914; http://dx.doi.org/10.1161/CIRCRESAHA.111.244442
9. Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure / clinical perspective. Circulation 2011; 124:1537-47; PMID:21900086; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.030932
10. Hu Y, Matkovich SJ, Hecker PA, Zhang Y, Edwards JR, Dorn GW, 2nd. Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs. Proc Natl Acad Sci U S A 2012; 109:19864-9; PMID:23150554; http://dx.doi.org/10.1073/pnas.1214996109
11. Matkovich SJ, Hu Y, Dorn GW, 2nd. Regulation of cardiac microRNAs by cardiac microRNAs. Circ Res 2013; 113:62-71; PMID:23625950; http://dx.doi.org/10.1161/CIRCRESAHA.113.300975
12. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ, Jr, Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009; 17:662-73; PMID:19922871; http://dx.doi.org/10.1016/j.devcel.2009.10.013
13. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007; 316:575-9; PMID:17379774; http://dx.doi.org/10.1126/science.1139089
14. Yang Y, Cheng H, Qiu Y, Dupee DK, Noonan M, Lin YD, Fisch S, Unno K, Sereti KI, Liao R. MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ Res 2015; 117:450-9; PMID:26082557; http://dx.doi.org/10.1161/CIRCRESAHA.117.305962
15. Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, et al. PI3K(p110 alpha) protects against myocardial infarction-induced heart failure:identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 2010; 30:724-32; PMID:20237330; http://dx.doi.org/10.1161/ATVBAHA.109.201988
16. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC, Menicanti L, Martelli F. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 2012; 61:1633-41; PMID:22427379; http://dx.doi.org/10.2337/db11-0952
17. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, et al. MicroRNAs in the human heart:a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116:258-67; PMID:17606841; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.687947
18. Yang JH, Li JH, Jiang S, Zhou H, Qu LH. ChIPBase:a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res 2013; 41:D177-87; PMID:23161675; http://dx.doi.org/10.1093/nar/gks1060
19. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008; 105:13421-6; PMID:18755897; http://dx.doi.org/10.1073/pnas.0801613105
20. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, Yokoi T. MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 2010; 285:4415-22; PMID:20018894; http://dx.doi.org/10.1074/jbc.M109.085431
21. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13:1353-60; PMID:22020437; http://dx.doi.org/10.1038/ncb2366
22. De Antonellis P, Carotenuto M, Vandenbussche J, De Vita G, Ferrucci V, Medaglia C, Boffa I, Galiero A, Di Somma S, Magliulo D, et al. Early targets of miR-34a in neuroblastoma. Mol Cell Proteomics 2014; 13:2114-31; PMID:24912852; http://dx.doi.org/10.1074/mcp.M113.035808
23. Wirsing A, Senkel S, Klein-Hitpass L, Ryffel GU. A systematic analysis of the 3′UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites. PLoS One 2011; 6:e27438; PMID:22140441; http://dx.doi.org/10.1371/journal.pone.0027438
24. El-Armouche A, Schwoerer AP, Neuber C, Emons J, Biermann D, Christalla T, Grundhoff A, Eschenhagen T, Zimmermann WH, Ehmke H. Common microRNA signatures in cardiac hypertrophic and atrophic remodeling induced by changes in hemodynamic load. PLoS One 2010; 5:e14263; PMID:21151612; http://dx.doi.org/10.1371/journal.pone.0014263
25. Wang Y, Men M, Yang W, Zheng H, Xue S. MiR-31 downregulation protects against cardiac ischemia/reperfusion injury by targeting protein kinase C epsilon (PKCepsilon) directly. Cell Physiol Biochem 2015; 36:179-90; PMID:25925791; http://dx.doi.org/10.1159/000374062
26. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genomics 2007; 31:367-73; PMID:17712037; http://dx.doi.org/10.1152/physiolgenomics.00144.2007
27. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105:13027-32; PMID:18723672; http://dx.doi.org/10.1073/pnas.0805038105
28. de Jong H, Neal AC, Coleman RA, Lewin TM. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart. Biochim Biophys Acta 2007; 1771:75-82; PMID:17197235; http://dx.doi.org/10.1016/j.bbalip.2006.11.007
29. Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, Zaha VG, Dyck JR, Abel ED, Young ME. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am J Physiol Heart Circ Physiol 2006; 290:H2480-97; PMID:16428347; http://dx.doi.org/10.1152/ajpheart.01344.2005
30. Wang J, Song Y, Zhang Y, Xiao H, Sun Q, Hou N, Guo S, Wang Y, Fan K, Zhan D, et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2012; 22:516-27; PMID:21844895; http://dx.doi.org/10.1038/cr.2011.132
31. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456:980-4; PMID:19043405; http://dx.doi.org/10.1038/nature07511
32. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, Zhang C. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010; 87:431-9; PMID:20219857; http://dx.doi.org/10.1093/cvr/cvq082
33. Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, et al. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 2013; 127:2097-106; PMID:23625957; http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000882
34. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014; 15:509-24; PMID:25027649; http://dx.doi.org/10.1038/nrm3838
35. Lal A, Thomas MP, Altschuler G, Navarro F, O'Day E, Li XL, Concepcion C, Han YC, Thiery J, Rajani DK, et al. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet 2011; 7:e1002363; PMID:22102825; http://dx.doi.org/10.1371/journal.pgen.1002363
36. Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure:signaling pathways and novel therapeutic targets. Arch Toxicol 2015; 89:1401-38; PMID:25708889; http://dx.doi.org/10.1007//s00204-015-1477-x
37. Xia J, Zhang Y, Xin L, Kong S, Chen Y, Yang S, Li K. Global transcriptomic profiling of cardiac hypertrophy and fatty heart induced by long-term high-energy diet in bama miniature pigs. PLoS One 2015; 10:e0132420; PMID:26161779; http://dx.doi.org/10.1371/journal.pone.0132420
38. Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011; 43:371-8; PMID:21423181; http://dx.doi.org/10.1038/ng.786
39. Agostini M, Knight RA. miR-34:from bench to bedside. Oncotarget 2014; 5:872-81; PMID:24657911; http://dx.doi.org/10.18632/oncotarget.1825
40. Bader AG. miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet 2012; 3:120; PMID:22783274; http://dx.doi.org/10.3389/fgene.2012.00120
41. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368:1685-94; PMID:23534542; http://dx.doi.org/10.1056/NEJMoa1209026
42. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/10.1186/gb-2009-10-3-r25
43. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR. Interpreting patterns of gene expression with self-organizing maps:methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 1999; 96:2907-12; PMID:10077610; http://dx.doi.org/10.1073/pnas.96.6.2907
44. Wong N, Wang X. miRDB:an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 2015; 43:D146-52; PMID:25378301; http://dx.doi.org/10.1093/nar/gku1104
45. Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0:decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014; 42:D92-7; PMID:24297251; http://dx.doi.org/10.1093/nar/gkt1248
46. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase:a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011; 39:D202-9; PMID:21037263; http://dx.doi.org/10.1093/nar/gkq1056
47. Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al. miRTarBase 2016:updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 2016; 44:D239-47; PMID:26590260; http://dx.doi.org/10.1093/nar/gkv1258
48. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45; PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45
49. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW, 2nd. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009; 119:1263-71; PMID:19237659; http://dx.doi.org/10.1161/CIRCULATIONAHA.108.813576
50. Wang X, Wang HX, Li YL, Zhang CC, Zhou CY, Wang L, Xia YL, Du J, Li HH. MicroRNA let-7i negatively regulates cardiac inflammation and fibrosis. Hypertension 2015; 66:776-85; PMID:26259595; http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05548
51. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007; 42:1137-41; PMID:17498736; http://dx.doi.org/10.1016/j.yjmcc.2007.04.004
52. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007; 100:416-24; PMID:17234972; http://dx.doi.org/10.1161/01.RES.0000257913.42552.23
53. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart:do they play a role in cardiac hypertrophy?. Am J Pathol 2007; 170:1831-40; PMID:17525252; http://dx.doi.org/10.2353/ajpath.2007.061170
54. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006; 103:18255-60; PMID:17108080; http://dx.doi.org/10.1073/pnas.0608791103
55. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK. MicroRNA expression in response to murine myocardial infarction:miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009; 82:21-9; PMID:19147652; http://dx.doi.org/10.1093/cvr/cvp015
56. Muthusamy S, DeMartino AM, Watson LJ, Brittian KR, Zafir A, Dassanayaka S, Hong KU, Jones SP. MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression. J Biol Chem 2014; 289:29665-76; PMID:25183011; http://dx.doi.org/10.1074/jbc.M114.578682
57. Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN, Hergenreider E, et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 2012; 119:1607-16; PMID:22184411; http://dx.doi.org/10.1182/blood-2011-08-373886
58. Veliceasa D, Biyashev D, Qin G, Misener S, Mackie AR, Kishore R, Volpert OV. Therapeutic manipulation of angiogenesis with miR-27b. Vasc Cell 2015; 7:6; PMID:26161255; http://dx.doi.org/10.1186/s13221-015-0031-1
59. Xu M, Wu HD, Li RC, Zhang HB, Wang M, Tao J, Feng XH, Guo YB, Li SF, Lai ST, et al. Mir-24 regulates junctophilin-2 expression in cardiomyocytes. Circ Res 2012; 111:837-41; PMID:22891046; http://dx.doi.org/10.1161/CIRCRESAHA.112.277418
60. Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D, Galuppo P, Kneitz S, Pena JT, Sohn-Lee C, et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011; 124:720-30; PMID:21788589; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.039008
61. Li RC, Tao J, Guo YB, Wu HD, Liu RF, Bai Y, Lv ZZ, Luo GZ, Li LL, Wang M, et al. In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circ Res 2013; 112:601-5; PMID:23307820; http://dx.doi.org/10.1161/CIRCRESAHA.112.300806
62. Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 2011; 208:549-60; PMID:21383058; http://dx.doi.org/10.1084/jem.20101547
63. Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J, Xu X, Hu S, Zheng Z. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 2012; 16:2150-60; PMID:22260784; http://dx.doi.org/10.1111/j.1582-4934.2012.01523.x
64. Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE. The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 2010; 137:1887-96; PMID:20460367; http://dx.doi.org/10.1242/dev.050526